Categories: News

uLab® Expands uDesign® Cloud Platform, Launches Reva®, and Hits New Operational Milestones

MEMPHIS, Tenn., July 10, 2025 /PRNewswire/ — uLab Systems®, a leader in orthodontic treatment planning software and aligner solutions, is proud to announce significant advancements across its service, platform, and product offerings—demonstrating its ongoing commitment to innovation, quality, and customer success.

On-Time, High-Quality Product Delivery You Can Count On
Since early this year, uLab has achieved over 98% on-time delivery of uSmile™ aligners—highlighting its commitment to operational excellence, reliability, and performance that dental professionals can trust. Quality-focused strategies have also driven noticeable gains in product consistency and customer satisfaction.

SmartRx™ Forms Mean Smarter Workflows and Enhanced uAssist Support
Efficient workflows are essential for dental professionals. The introduction of SmartRx™ forms in the uDesign® Cloud has reduced modification cycles for uAssist® cases, streamlining planning and speeding up case acceptance. Expansion within the uAssist support team also reinforces uLab’s commitment to personalized service.

New: Reva® Thermoforming Sheets
uLab recently launched Reva® thermoforming sheets on shopulab.com, offering dental professionals a high-quality, in-office aligner material that complements the uSmile experience. Designed for clarity, strength, and a slimmer profile, Reva enables fast thermal response and easy cutting and post-processing. Introductory discounts are available for a limited time.

Coming Soon to the uDesign Cloud
Looking ahead, uLab is expanding the capabilities of the uDesign Cloud—launched in April—by bringing over key tools from the full-featured, industry-leading chairside uDesign Desktop software. In the coming months, several popular features will roll out as they become available, with even more significant updates planned next year:

  • STL Export for in-office printing
  • IPR Staging Modifications for precise interproximal planning
  • Treatment Velocity Adjustment for tailored movement pacing
  • Multiple Tooth Movement capabilities for streamlined edits
  • Tooth Segmentation (manual and auto)
  • Internal Workflow Assignment Functions to enhance team collaboration
  • Scanner Integrations to simplify data import and case setup with major scanner brands

“These updates are all about giving our customers more control, more speed, and more choices,” said Gary Les, CEO at uLab Systems. “We’re committed to supporting dental professionals with flexible tools that fit their workflow, whether they are in the clinic, at home, or on the go.”

For more information on uLab Systems and its solutions, visit www.ulabsystems.com.

About uLab Systems
uLab Systems® is transforming orthodontics with advanced digital treatment planning software that empowers dental professionals to take full control of their cases. With a customer-first mindset and a focus on innovation, uLab supports practice growth through its uDesign® software, uAssist® service, and uSmile™ aligners—available nationwide. uSmile aligners are sustainably made in Memphis, Tennessee, with over 80% of mold materials recycled.

Media Contact: Johanna Beckmen, VP of Marketing and Commercial Operations, pr@ulabsystems.com

© 2025 uLab Systems, Inc. All Rights Reserved. uSmile is a trademark and uLab, uLab Systems, uDesign, uAssist, and Reva are registered trademarks of uLab Systems, Inc. MAR-0001929 Rev 1

View original content to download multimedia:https://www.prnewswire.com/news-releases/ulab-expands-udesign-cloud-platform-launches-reva-and-hits-new-operational-milestones-302502080.html

SOURCE uLab Systems, Inc.

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

1 hour ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

1 hour ago